← Back to headlines
Experimental Immunotherapy Shows Promising Results in Bowel Cancer Trial
Patients in a new bowel cancer immunotherapy trial have remained cancer-free for nearly three years after receiving pembrolizumab before surgery, marking a significant breakthrough.
4 May, 21:02 — 4 May, 21:02
Related Stories
Cavite to Host First PGH Site Outside Metro Manila
just now
Jay Sonza Released on Bail, Arraignment Deferred
just now
Lithuanian Woman Gintarė Panasiuk Develops Diet-Free Weight Loss Program After Losing 45kg
19m ago
Médio Tejo Region to Host Seminar on Public Health System and Extreme Weather Response
21m ago